FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood SugarNew device can help people with diabetes detect warning signs of a dangerous complication before it becomes a medical emergency 
FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood SugarThe U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes. Sign in to join the conversation